50
Participants
Start Date
September 1, 2025
Primary Completion Date
September 1, 2029
Study Completion Date
September 1, 2029
Transcranial Magnetic Stimulation Device
Transcranial magnetic stimulation uses FDA-approved coils to generate varying magnetic fields in the brain of the participant and induce an electric field in the underlying brain tissue. The standard intermittent Theta Burst Stimulation (iTBS) TMS protocol will be applied in this study. The same coil can be applied to generate sham stimulations that only generate sound and stimulations to the scalp without stimulating the brain.
MGH at the Navy Yard, Charlestown
Massachusetts General Hospital
OTHER
National Institute of Mental Health (NIMH)
NIH
Brigham and Women's Hospital
OTHER